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Abstract
Background: Despite sustained exposure to a person with pulmonary tuberculosis (TB), some M. tuberculosis
(Mtb) exposed individuals maintain a negative tuberculin skin test (TST). Our objective was to characterize these
persistently negative TST (PTST-) individuals and compare them to TST converters (TSTC) and individuals who are
TST positive at study enrollment.
Methods: During a TB household contact study in Kampala, Uganda, PTST-, TSTC, and TST + individuals were
identified. PTST- individuals maintained a negative TST over a 2 year observation period despite prolonged exposure
to an infectious tuberculosis (TB) case. Epidemiological and clinical characteristics were compared, a risk score
developed by another group to capture risk for Mtb infection was computed, and an ordinal regression was
performed.
Results: When analyzed independently, epidemiological risk factors increased in prevalence from PTST- to TSTC to
TST+. An ordinal regression model suggested age (p < 0.01), number of windows (p < 0.01) and people (p = 0.07) in
the home, and sleeping in the same room (p < 0.01) were associated with PTST- and TSTC. As these factors do not
exist in isolation, we examined a risk score, which reflects an accumulation of risk factors. This compound exposure
score did not differ significantly between PTST-, TSTC, and TST+, except for the 5–15 age group (p = 0.009).
Conclusions: Though many individual factors differed across all three groups, an exposure risk score reflecting a
collection of risk factors did not differ for PTST-, TSTC and TST + young children and adults. This is the first study to
rigorously characterize the epidemiologic risk profile of individuals with persistently negative TSTs despite close
exposure to a person with TB. Additional studies are needed to characterize possible epidemiologic and host factors
associated with this phenotype.
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Background
Tuberculosis (TB) is an infectious disease caused by
Mycobacterium tuberculosis (Mtb). There are an esti-
mated 8 million new cases and 2 million deaths from TB
annually. Uganda is one of the world’s 22 highest burden
countries with TB, with an annual risk of infection of 3%
and annual incidence of new smear positive TB cases of
9.2 per 1000 in an urban setting [1].
Transmission of Mtb requires repeated close contact
with someone who has active pulmonary TB and the
likelihood of transmission increases with increasing levels
of contact. Therefore, it is not surprising that markers of
close contact, such as crowded quarters, urban living, and
lower socio-economic status, are associated with acquisi-
tion of Mtb [2,3]. Clinical characteristics of the person
with pulmonary TB that increase the risk of contacts be-
coming infected include cavitary disease, sputum smear
grade, and extent of disease based on x-ray [4-8].
The pathogenesis of TB follows a two-stage process
[8]. Infection is the first stage, where, Mtb infection is
contained but not eliminated by the innate and adaptive
immune response. The second stage consists of progres-
sion from infection to active disease, and presents with
signs and symptoms caused by the increasing mycobac-
terial load and the host response; 5-10% of individuals
infected with Mtb develop clinical disease. Interestingly,
a small percentage of individuals in TB-endemic settings
never demonstrate evidence of latent Mtb infection des-
pite persistent and repeated exposure. These individuals
consistently test negative by the tuberculin skin test (TST)
and/or interferon-γ response assay [9]. Persistently TST
negative (PTST-) individuals may be (relatively) resistant
to Mtb infection, and little is known about them [10]. Pre-
vious population-based and case-contact studies have
identified epidemiological risk factors for infection [2,11]
but have not characterized PTST- individuals specifically.
A few studies in healthcare settings have identified PTST-
individuals [12-14] but these studies were limited in their
duration of follow-up and sample size, and because they
were conducted in health care settings, not generali-
zable to a population-based setting. Though we have ex-
amined immunological and genetic correlates of the
PTST- phenotype [9,15], these individuals have not been
thoroughly characterized epidemiologically. This study
examines well-characterized risk factors for Mtb infec-
tion to determine if specific epidemiologic factors ex-
plain the PTST- phenotype, and to assess whether they
are simply less likely to acquire Mtb infection.
Methods
Study population
The study was approved by University Hospitals Institu-
tional Review Board at University Hospitals Case Medical
Center in the United States and the National HIV/AIDS
Research Committee and Uganda National Council for
Science and in Uganda, and all participants provided in-
formed consent [2]. The household contact study [16]
started enrolling culture-confirmed TB patients and their
households in Kampala, Uganda in April 2002, and this
analysis includes patients enrolled through January 1,
2008 and followed through December 2010. An index
case was defined as the first identified culture-confirmed
TB case in the household. Most index cases presented
with TB to the Uganda National Tuberculosis and Leprosy
Program treatment center at the Old Mulago Hospital in
Kampala, Uganda. Some participants also came to the
study after hearing about the study via other sources.
Home visits were made within 2 weeks of index case’s
diagnosis, and household contacts were recruited into
the study. A household contact was defined as an indi-
vidual who had resided in the household for at least 7
consecutive days during the 3 months prior to diagnosis
of TB in the index cases. The analyses presented here
excluded individuals who had TB in the past, were diag-
nosed with active TB disease at the time of enrollment,
or who developed TB during the course of the study.
Index cases and all other active TB cases were provided
standard treatment regimens (except in rare cases of mul-
tidrug resistant TB when appropriate second line treat-
ment was given). Patients were monitored clinically and
repeat sputum samples obtained at 1, 2, 5, and 9 months
after treatment initiation. After the initial evaluation, par-
ticipants were evaluated at 3, 6, 12, and 24 months for ac-
tive TB and with repeat TST if their first and subsequent
TST remained negative. All individuals were monitored
clinically and if signs and symptoms of TB developed,
evaluated as TB suspects. Tuberculin skin testing was
done using 5 TU of purified protein derivative (PPD). HIV
status was determined by serology.
Data
Each participant received a full clinical examination, in-
cluding overall health and symptom survey, chest x-ray,
mycobacterial smear, and TST. Sputum smear was classi-
fied based on WHO criteria. Latent Mtb infection (TST+)
was defined as a reading of at least 5 mm of induration in
response to PPD in children less than 5 years old or HIV-
infected individuals, and 10 mm in all other individuals, at
the time of enrollment [17,18]. TST conversion (TSTC)
was defined as a positive TST that occurred after a nega-
tive TST with at least a 6 mm increase in induration
[15,19]. TST + persons were defined as those with a posi-
tive TST at enrollment. Vaccination by Bacillus Calmette-
Guerin (BCG) was determined by the presence of BCG
scar. Extensive epidemiologic and clinical data were col-
lected on individual risk factors, proximity to the index
case, and characteristics of the household [2]. Mycobacter-
ial lineage of the TB index case was identified as described
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by Wampande et al. [20] using the phylogenetic groupings
proposed by Gagneux [21].
Statistical analysis
Age categories were designated based on previous exam-
ination of clinically and immunologically defined group-
ings [22]. Comparisons were first made across the three
clinical groups (PTST-, TSTC, and TST+), then by con-
trasting PTST- and TSTC versus TST + (baseline TST
status comparison), and by PTST- to TSTC and TST +
(PTST- vs. ever becoming TST positive) persons. Cat-
egorical variables were analyzed using the χ2 test; be-
cause all continuous variables were skewed, they were
analyzed using the Mann–Whitney U test. Multiple test-
ing correction was done to account for 22 variable com-
parisons × 2 functionally independent χ2 tests, resulting
in an adjusted α = 0.0011. Nominal P-values are provided
in the Tables, with tests significant after correction for
multiple testing indicated with asterisks (*). SPSS version
20 was used.
Ordinal regression
Multivariable logistic regression analyses, with baseline
TST status as one outcome and longitudinal TST status
(PTST-) as the other were initially conducted. However,
we found that the same predictor variables were signifi-
cantly associated with both outcomes (data not shown).
Thus, we conducted an ordinal regression analysis to pro-
vide a multivariable analysis to identify which variables
from the univariate analyses remained significant while
controlling for the others. Logistic regression was ap-
plied to an ordinal response variable with order PTST- <
TSTC <TST+, using a proportional-odds model as imple-
mented in the VGAM package for R [23]. The model fit
logit(Pr(y ≤ j)) = α + βx for j = 1 (PTST-), 2 (TSTC). Valid-
ity of the proportional odds assumption was tested by a
likelihood ratio test comparing models with and without
the constraint that the odds ratio corresponding to each
covariate was the same at each level of the response. A set
of optimal covariates was obtained via forward stepwise
selection, using P = 0.1 as the threshold for entry.
Risk score
Mandalakas et al. [11] developed a risk score for latent
Mtb infection in children that included 10 variables that
increased the likelihood of transmission, and consisted
of clinical characteristics and proximity to the index
case. While the ordinal regression illustrates the signifi-
cance of individual risk factors in the context of others,
this risk score captures an additive accumulation of risk
factors. All but one of the variables included in their 10-
point score were collected as part of our study (we did
not ask “is the index case the child’s primary caregiver?”)
(see Additional file 1 for complete list). We evaluated
this risk score and conducted statistical comparisons de-
scribed above, stratified by age given its established con-
founding effect (Additional file 1: Tables S3 and S4).
Mandalakas et al.’s risk score was developed for children,
so we modified it for adults. Instead of including the mo-
ther as index case as risk category, we used the spouse of
index case, and instead of the index case being the individ-
ual’s primary care giver, we included whether the adult
was the index case’s primary caregiver (see Additional
file 1). Thus, the score for adults went up to 10, and we
retained this greater variability to increase the informa-
tivity of the score. The risk score was analyzed both as a
categorical and quantitative variable. Mandalakas et al.
proposed that a score ≥ 6 out of 10 was considered “high
risk”; since our pediatric score only ranged to 9, we con-
sidered children with scores ≥ 5 and adults with scores ≥
6 to be “high risk”.
Results
Data were collected on 1318 individuals from 454 house-
holds from April 2002 to January 2008, in which 1210
household contacts had at least one year (12 months) of
TSTs in individuals who were TST negative at baseline
and did not develop culture-confirmed TB during two
years of follow-up; 900 (74.4%) were TST + at baseline,
168 (13.8%) converted their TST, and 142 (11.7%) were
persistently TST- (PTST-). The remaining 108 individuals
were TST- at baseline but did not have follow-up TSTs
(TST follow-up rate of 91.8%), and thus were excluded
from this analysis. When individuals that were lost to
follow-up were compared to those in the analysis dataset,
the only difference was in the 5–15 age group (p = 0.008),
where 11.9% were lost to follow-up, compared to less than
10% for the other age groups (data not shown).
Comparison of epidemiologic risk factors for PTST-, TSTC
and TST + contacts
We found that there were no significant differences in
the distributions of sex, HIV status, or presence of BCG
scar across the 3 clinical groups (Table 1). There was a
significant difference in the distribution of age groups
across the 3 clinical groups, which was most pronounced
for the 5 to 15 age group, in which 45.8% of PTST- were
5 to 15, compared to 28.0% and 26.3% of this age group
in the TSTC and TST + categories (P < 0.0005). PPD in-
duration at baseline was also significantly different across
groups (P < 0.0005). To further examine this difference
between PTST- and TSTC, we examined the proportion
of HIV-negative individuals older than 5 years of age
with TST induration greater than 5 mm (Additional file 1:
Table S1), and found that there was a significantly greater
proportion of TSTC with this more conservative TST cut-
off. However, the more stringent 10 mm cutoff is more
appropriate in this TB-endemic setting [18], given the
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potential for cross-reactivity with BCG vaccination and
resulting misclassification, so the 10 mm cutoff was used
for all further analyses.
Factors associated with transmission of Mtb and in-
creased risk for Mtb infection (eg. share room/bed with
index case) generally differed across all 3 clinical groups,
with a gradual increase of the high-risk category from
PTST- to TSTC to TST+, though not all comparisons
achieved statistical significance after multiple testing cor-
rection (Tables 2 and 3). Characteristics associated with
small homes, such as number of windows and number of
rooms, were less common for PTST- compared to the
other groups, though there was a reverse trend in number
of people per room (Table 2). Muzigos, which are multi-
family housing units with one or two rooms per family
[2], were less common for individuals who were TST
negative at baseline compared to those who were TST + at
baseline (P = 0.001); this may represent poorer socioeco-
nomic status and/or close living quarters. Clinical charac-
teristics of the index case, such as presence of cavitary
disease and increased growth of Mtb on smear, followed
a similar trend (Table 3), with increasing severity of
TB disease in the index case more common in TSTC
and TST+. There was a significantly different distri-
bution in relationship to the index case in individuals
who were baseline TST negative versus TST positive
(P = 0.003); there were more spouses or parents of the
index case among TST + persons than among PTST- and
TSTC (Table 2). There was no association between Mtb
lineage in the index case and clinical group. In addition,
we divided the PTST- group into those who were TST-
at 12 months but lost to follow-up prior to the 24
month visit, versus those we were TST- at 24 months
and found no differences between groups (Additional
file 1: Table S2).
Ordinal regression analysis
Since we observed that the prevalence of individual risk
factors was highest in TST+, followed by TSTC and then
PTST-, we conducted an ordinal regression analysis
(Table 4). Because of the parameterization of this model,
an odds ratio > 1 is interpreted as increased “risk” of
PTST- vs. TSTC, and an increased “risk” of TSTC vs.
TST+. Thus, individuals age > 15 (OR = 0.43 P < 0.01)















Age at baseline (years)
2 years or less 19 (13.4%) 22 (13.1%) 103(11.4%) 144(11.9%)
>2 and equal to 5 27(19.0%) 24(14.3%) 93(10.3%) 144(11.9%)
>5 or less than 15 65 (45.8%) 47 (28.0%) 237 (26.3%) 349 (28.8%)
>15 31 (21.8%) 75 (44.6%) 467 (51.9%) 573 (47.3%)
All 142 168 900 1210 < 0.0005* <0.0005* < 0.0005*
Sex
Female 73 (51.4%) 98 (58.3%) 488 (54.2%) 659 (54.5%)
Male 69 (48.6%) 70 (41.7%) 412 (45.8%) 551 (45.5%)
All 142 168 900 1210 0.456 0.437 0.775
HIV status
Negative 127 (91.4%) 157 (96.9%) 801 (92.5%) 1085 (93%)
Positive 12 (8.6%) 5 (3.1%) 65 (7.5%) 82 (7.0%)
All 139 162 866 1167 0.095 0.430 0.277
Presence of BCG scar
No 27 (19.0%) 32 (19.0%) 184 (20.4%) 243 (20.1%)
Yes 93 (65.5%) 117 (69.6%) 627 (69.7%) 837 (69.2%)
Uncertain 22 (15.5%) 19 (11.3%) 89 (9.9%) 130 (10.7%)
All 142 168 900 1210 0.381 0.151 0.254
PPD at baseline (mm)1
Mean (SD) 0.30 (1.153) 1.87 (3.238) 15.91 (3.605) N/A N/A N/A
PTST- = Persistently negative tuberculin skin test; TSTC = Tuberculin skin test converter; TST + = tuberculin skin test positive at baseline.
*indicates P value that is significant after multiple testing correction.
1Statistical comparisons of these three groups must account for age group; see further detail in Additional file 1.
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Table 2 Individual epidemiological measures











Share bed with index case
No 122 (85.9%) 140 (83.3%) 698 (77.6%) 960 (79.3%)
Yes 20 (14.1%) 28 (16.7%) 202 (22.4%) 250 (20.7%)
All 142 168 900 1210 0.028 0.039 0.009
Share room with index case
No 65 (45.8%) 83 (49.4%) 297 (33.0%) 445 (36.8%)
Yes 77 (54.2%) 85 (50.6%) 603 (67.0%) 765 (63.2%)
All 142 168 900 1210 <0.0005* <0.0005* <0.0005*
Share meals with index case
No 14 (9.9%) 16 (9.5%) 65 (7.2%) 95 (7.9%)
Yes 128 (90.1%) 152 (90.5%) 835 (92.8%) 1115 (92.1%)
All 142 168 900 1210 0.380 0.344 0.166
Type of house (muzigo vs other)
Not Muzigo 75 (52.8%) 95 (56.9%) 397 (44.4%) 567 (47.1%)
Muzigo 67 (47.2%) 72 (43.1%) 497 (55.6%) 636 (52.9%)
All 142 167 894 1203 0.004 0.148 0.001*
Frequency of contact with index case
<1 day/wk 1 (0.7%) 2 (1.2%) 19 (2.1%) 22 (1.8%)
1-3 day 6 (4.2%) 7 (4.2%) 38 (4.2%) 51 (4.2%)
4-6 days 7 (4.9%) 5 (3.0%) 24 (2.7%) 36 (3.0%)
daily 129 (90.1%) 153 (91.1%) 816 (90.7%) 1097 (90.7%)
Total 142 167 897 1206 0.740 0.536 0.593
Time spent with index case (hours)
<1 3 (2.1%) 5 (3.0%) 19 (2.1%) 27 (2.3%)
2-6 17 (12.1%) 16 (9.5%) 78 (8.8%) 111 (9.3%)
7-12 70 (49.6%) 87 (51.8%) 511 (57.5%) 668 (55.8%)
13-18 29 (20.6%) 38 (22.6%) 162 (18.2%) 229 (19.1%)
>18 22 (15.6%) 22 (13.1%) 118 (13.3%) 162 (13.5%)
Total 141 168 888 1197 0.659 0.339 0.539
Number of windows in house
Mean (SD) 2.6 (2.773) 2.64 (2.475) 1.87 (2.056) <0.0005* < 0.0005* 0.029
Number of rooms in house
Mean (SD) 3.44 (3.183) 3.26 (2.541) 2.70 (2.383) <0.0005* < 0.0005* 0.041
# People in household/room
Mean 7.80 (5.235) 6.76 (4.129) 6.10 (3.672) <0.0005* < 0.0005* < 0.0005*
Number of TB cases in home
Mean 1.67 (0.98) 1.66 (0.867) 1.61 (.896) 0.985 0.363 0.799
Relationship to index case
Spouse 6 (4.2%) 10 (6.0%) 122 (13.6%) 138 (11.4%)
Parent 3 (2.1%) 5 (3.0%) 48 (5.3%) 56 (4.6%)
Sibling 23 (16.2%) 22 (13.1%) 113 (12.6%) 158 (13.1%)
Avuncular 24 (16.9) 29 (17.3%) 128 (14.2%) 181 (15.0%)
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that slept in the same room as the index case (OR 0.66
P < 0.01) were less likely to be PTST-, and increasing
number of windows in the home (beta = 1.10 P < 0.01)
and greater number of people in the home (beta = 1.03
P < 0.01) were also associated with PTST-. The same inter-
pretation can be made for TSTC versus baseline TST+.
Thus, age, sleeping with the index case, ventilation, and
crowding were independently associated with increased
risk of TST conversion versus PTST-, and TST conversion
versus pre-existing latent Mtb infection.
Risk score
Next, we examined a risk score (Figure 1) [11], that was
evaluated differently for children less than 15 years old
(Additional file 1: Table S3) versus adults 15 years and
older (Additional file 1: Table S4). Because our earlier
Table 2 Individual epidemiological measures (Continued)
Child 59 (41.5%) 66 (39.3%) 325 (36.1%) 450 (37.2%)
Grandparent/Child 3 (2.1%) 4 (2.4%) 18 (2.0%) 25 (2.1%)
Unrelated 21 (14.8%) 27 (16.1%) 126 (14.0%) 174 (14.4%)
Other relative 3 (2.1%) 5 (3.0%) 20 (2.2%) 28 (2.3%)
Total 142 168 900 1210 0.060 0.102 0.003
PTST- = Persistently negative tuberculin skin test; TSTC = Tuberculin skin test converter; TST + = tuberculin skin test positive at baseline.
*indicates P value that is significant after multiple testing correction.
Table 3 Clinical characteristics of index case by clinical group
PTST- TSTC TST+ All χ 2 across
all 3 groups
χ 2 for PTST- +
TSTC vs. TST+
χ 2 for PTST- vs.
TSTC and TST+
Presence of Cavitary Disease
No 74 (53.2%) 75 (45.5%) 306 (34.7%) 455 (38.4%)
Yes 65 (46.8%) 90 (54.5%) 576 (65.3%) 731 (61.6%)
All 139 165 882 1186 <0.005* <0.005* <0.005*
Baseline Extent of disease on chest x-ray
Normal 18 (12.9%) 9 (5.5%) 40 (4.5%) 67 (5.6%)
Minimal 22 (15.8%) 22 (13.3%) 81 (9.2%) 125 (10.5%)
Moderate 58 (41.7%) 76 (46.1%) 305 (34.6%) 439 (37.0%)
Advanced 41 (29.5%) 58 (35.2%) 456 (51.7%) 555 (46.8%)
All 139 165 882 1186 <0.005* <0.005* <0.005*
High Index case Smear
None 4 (2.8%) 3 (1.8%) 14 (1.6%) 21 (1.7%)
Scanty 5 (3.5%) 1 (0.6%) 11 (1.2%) 17 (1.4%)
1+ 13 (9.2%) 4 (2.4%) 21 (2.3%) 38 (3.1%)
2+ 31 (21.8%) 39 (23.2%) 89 (9.9%) 159 (13.1%)
3+ 89 (62.7%) 121 (72%) 765 (85%) 975 (80.6%)
Total 142 168 900 1210 <0.005* <0.005* <0.005*
Duration of Cough prior to treatment (days)
Mean (SD) 123.48 (155.876) 118.75 (124.032) 119.49 (119.597) 0.150 0.057 0.998
Mycobacterial lineage
Lineage 4 Uganda 57 (46.3%) 71 (47.7%) 415 (54.0%) 543 (52.2%)
Lineage 4 non_Uganda 49 (39.8%) 60 (40.3%) 280 (36.4%) 389 (37.4%)
Lineage 3 17 (13.8%) 18 (12.1%) 74 (9.6%) 109 (10.5%)
Total 123 149 769 1041 0.308 0.101 0.269
PTST- = Persistently negative tuberculin skin test; TSTC = Tuberculin skin test converter; TST + = tuberculin skin test positive at baseline; CI = confidence interval.
Lineage 4 is also known as Euro-American and Lineage 3 is also known as Central Asian [20].
*indicates P value that is significant after multiple testing correction.
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analyses (Table 1) showed that age was a significant pre-
dictor of TST status and thus a confounder, we stratified
by age group at the outset. This risk score demonstrated
that all the children were highly exposed, with 95% hav-
ing scores of 5 and above (Table 5). Furthermore, we ob-
served no significant difference in the distribution of
scores between the 3 clinical groups for the 0–2 and 2–5
age groups. In the 5–15 age group only, there were sig-
nificant differences across the three groups (P = 0.009).
In adults, there was no significant difference between
the clinical groups in the distribution of the scores.
Adults had a slightly lower degree of risk, with the per-
centage of individuals with scores of 6 and above ran-
ging between 74.2% in PTST- to 90.8% in TSTC, though
this difference was not statistically significant (Table 5
and Additional file 1: Table S4). When analyzing the risk
score as a quantitative variable (Figure 1), the same con-
clusions can be drawn, with significant differences only
occurring in the 5–15 age group (P = 0.006).
Then, we stratified the adults into high and low risk
groups according to this risk score, and re-analyzed the
variables that were significant in our earlier analyses in
Tables 2 and 3 but were not part of the risk score. Re-
sults are shown in Table 6. In the high-risk group, there
were no longer differences between PTST- individuals
and TSTC and TST+. Interestingly, this analysis de-
monstrated that the variables that were significant in
the ordinal regression were no longer significant after
Table 4 Ordinal regression analysis of PTST- vs TSTC and TSTC vs TST+
Univariate model Multivariable model
Predictor OR 95% CI P OR 95% CI P
Intercept 1 — — 0.146 (0.090, 0.24)
Intercept 2 — — 0.400 (0.25, 0.65)
Age 2–5 vs 0-2 1.43 (0.88, 2.32) 0.15 1.34 (0.82, 2.20) 0.24
Age 5–15 vs. 0-2 1.24 (0.82, 1.89) 0.31 1.04 (0.68, 1.60) 0.85
Age 15+ vs 0-2 0.553 (0.37, 0.84) < 0.01 0.431 (0.28, 0.66) < 0.01
No. of Windows 1.145 (1.09, 1.21) < 0.01 1.097 (1.02, 1.18) < 0.01
Sleep in Same Room 0.559 (0.43, 0.72) < 0.01 0.66 (0.48, 0.89) < 0.01
People in Home 1.070 (1.04, 1.10) < 0.01 1.033 (1.00, 1.07) < 0.01
PTST- = Persistently negative tuberculin skin test; TSTC = Tuberculin skin test converter; TST + = tuberculin skin test positive at baseline; CI = confidence interval.
Univariate model results show results for each variable one at a time, while the multivariable model includes all variables. Model parameterized as logit(Pr(y ≤ j)) =
α + βx for j = 1 (PTST-), 2 (TSTC). Each OR shows the odds or PTST vs TSTC and also TSTC vs TST + .
A B
Figure 1 Boxplot illustrating distribution of risk scores by clinical group in A) children < 15 years old (range 0 to 9) and B) adults
(range 0 to 10). PTST- (blue) = persistent TST negative, TSTC (green) = TST converter, and TST+ (red) = TST positive at baseline.
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accounting for an accumulation of other factors. Differ-
ences between individuals that were TST negative versus
positive at baseline persisted (P < 0.0005, Table 6).
Discussion
Although many studies have evaluated risk factors for
Mtb infection, few have looked at PTST- individuals. This
large longitudinal study provides a unique opportunity to
consider epidemiological factors associated with relative
resistance to Mtb infection. Our study assessed household
factors, individual factors, and index case characteristics
that have been previously associated with presence of Mtb
infection [2,4,5,11]. Several factors related to exposure
intensity showed increasing prevalence from PTST- to
TSTC to TST+. However, these risk factors do not exist
in isolation, so the examination of a risk score such as
that developed by Mandalakas et al. [11] may be more
appropriate, as it reflects an accumulation of risk factors.
We observed no significant differences in risk score distri-
bution by TST status except in the 5–15 age group. Thus,
when considering epidemiologic risk as an accumulation
of risk factors, PTST- is not determined by decreased epi-
demiologic risk in young children and adults.
The 5–15 age group is the only group where differ-
ences were seen in the epidemiologic risk score between
PTST-, TSTC and TST+. There are several possible ex-
planations for this observation. First, children in this age
group start attending school, and thus may start to have
exposure to TB cases outside the home. Second, we
have previously observed a significant difference in Mtb-
specific interferon-γ responses in 5–15 year olds com-
pared to younger children [22], reflecting the so-called
“golden age of immunity”. The risk of progression from
infection to disease is also lowest in the 5–10 year range
[24], further reflecting a developing immune response.
One of the major characteristics of the PTST- group is
a significantly younger age distribution that likely reflects
less cumulative exposure to Mtb. Though sharing a bed
was significantly different in the three clinical groups, this
is likely because the youngest individuals are PTST-, and
children are most likely to share a bed with their parent.
When analyses were stratified by age group, factors such
as sharing meals with the index case, severity of disease in
the index case, crowding, and poor ventilation, that were
previously statistically significant no longer were associa-
ted (data not shown). TST induration at baseline was also
Table 5 Number of individuals by clinical group
considered “high risk” according to Mandalakas et al.
criteria
PTST- TSTC TST+
2 years or less 19/19 (100%) 21/22 (95.5%) 101/103 (98.1%)
>2 and equal to 5 27/27 (100%) 24/24 (100%) 93/93 (100%)
>5 or less than 15 62/65 (95.4%) 45/47 (95.7%) 231/237 (97.5%)
>15 23/31 (74.2%) 68/75 (90.7%) 410/467 (87.8%)
“High risk” is defined as a pediatric risk score ≥5 out of 9, or an adult risk
score ≥6 out of 10. Components of the risk score can be found in the
Additional file 1, No statistically significant differences seen across clinical
groups within age group (p > 0.05).
PTST- = Persistently negative tuberculin skin test; TSTC = Tuberculin skin test
converter; TST + = tuberculin skin test positive at baseline.
Table 6 Examination of “high risk” adults (age > 15) for key risk factors (N (%))
PTST- TSTC TST+ Comparison
across all 3 groups
Comparison of PTST-
vs TSTC + TST+
Comparison of PTST-
and TSTC vs TST+
Characteristics of household
Number of windows in house
Mean (SD) 3.48 (3.25) 3.10 (2.78) 1.93 (2.03) < 0.0005 0.056 < 0.0005
Number of rooms in house
Mean (SD) 4.26 (4.06) 3.87 (3.23) 2.77 (2.42) 0.002 0.096 < 0.0005
# People in household/room
Mean (SD) 8.22 (7.30) 7.30 (5.88) 5.99 (3.93) 0.198 0.259 0.030
Characteristics of index case
Presence of cavitary disease
No 12 (54.5%) 28 (42.4%) 155 (38.4%)
Yes 10 (45.5%) 38 (57.6%) 249 (61.6%) 0.290 0.181 0.231
Baseline extent of disease on chest x-ray
Normal 3 (13.6%) 5 (7.6%) 13 (3.2%)
Minimal 5 (22.7%) 7 (10.6%) 44 (10.9%)
Moderate 7 (31.8%) 29 (43.9%) 145 (35.9%)
Advanced 7 (31.8%) 25 (37.9%) 202 (50.0%) 0.069 0.085 0.033
“High risk” defined as a score ≥ 6 out of 10 on risk score (based on Mandalakas et al. criteria).
PTST- = Persistently negative tuberculin skin test; TSTC = Tuberculin skin test converter; TST + = tuberculin skin test positive at baseline.
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significantly different between PTST- and TSTC [15,25],
suggesting that some individuals who were TST- at en-
rollment were progressing toward TST conversion, or
perhaps that standard TST cutoff values resulted in
misclassification.
A limitation of this analysis is that we did not conduct
interferon-γ response assays (IGRA), on these study sub-
jects to verify Mtb infection status. Many of these study
participants were enrolled prior to the availability of
the highly Mtb-specific IGRA. IGRAs were designed to
avoid concerns of cross-reactivity with BCG and to allay
concerns about boosting effects after repeated TSTs
[19,26,27]. Indeed, our previous work shows that TSTC
have a higher whole blood interferon-γ response at
baseline than PTST- [15], so it is possible that an IGRA
would have distinguished these two groups at baseline.
However, the sensitivity [26,27] and cost-effectiveness
[28] of IGRAs in TB-endemic settings is still a topic
of debate. In addition, the risk score developed by
Mandalakas et al. [11] can be used as a proxy for asses-
sing infection, and the authors propose their risk score
could be used in lieu of the TST or IGRA. However, this
risk score has not been validated in independent studies,
and in fact, our results suggest that the score does not
associate with latent Mtb infection as was its devel-
oped purpose. In addition, the population studied by
Mandalakas et al. was restricted to HIV negative indi-
viduals. Though our analyses included HIV positive indi-
viduals, their influence on the analysis was minimal, as
only 1.7% of 0–2 year olds and 2.6% of 2–5 year olds were
HIV positive. Furthermore, studies have shown that IGRA
positivity is associated with indicators of recent and close
Mtb exposure [26,27], which we have captured with the
risk score. Another limitation is that there may be un-
measured exposure factors that could characterize PTST-
individuals. We believe this is unlikely because our data
collection was extensive.
Conclusions
In summary, we examined a number of well-established
variables associated with Mtb infection and disease, and
found that a risk score consisting of factors associated
with transmission of Mtb did not distinguish PTST- in-
dividuals from those who eventually convert their TST
or were TST positive at baseline. There are likely host
factors, such as host genetics [9] and immune response
[15] that explain why these individuals remain relatively
resistant to Mtb infection. Alternatively, unmeasured com-
ponents of shared environment, such as nutrition [29,30]
or quantity of Mtb bacilli in the air [31-33], may potentially
explain why some individuals remain PTST-. Further study
is needed to examine the combined influences of genetics,
immunology, and nutrition on resistance to Mtb infection,
as well as explore additional epidemiological factors.
Additional file
Additional file 1: Supplemental material.
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